RPL5 was heterozygously deleted in 8.4% of GBM and 25.3% of SKCM patients and in both cancers the RPL5 gene locus was positioned in a distinct focal peak of deletion (Figure 2C). The gene discussed is RPL5; the disease is glioblastoma.